| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 5.6M -1.2% | 5.7M +6.2% | 5.4M -14.0% | 6.3M +18.5% | 5.3M |
| R&D | 3.3M -6.8% | 3.6M +12.7% | 3.2M -25.6% | 4.3M +45.4% | 2.9M |
| SG&A | 2.3M +8.4% | 2.1M -0.8% | 2.2M +11.1% | 1.9M -15.5% | 2.3M |
| Operating Income | -5649932 +1.2% | -5719456 -6.2% | -5385377 +14.0% | -6262305 -18.5% | -5284595 |
| EBITDA | -5649932 +1.1% | -5713148 -7.2% | -5328032 +14.1% | -6204961 -18.7% | -5227251 |
| Net Income | -5605070 +0.7% | -5645532 -7.1% | -5270299 +13.2% | -6069475 -19.3% | -5087557 |
| EPS (Basic) | $-0.68 +0.0% | $-0.68 +2.9% | $-0.70 +9.1% | $-0.77 +21.4% | $-0.98 |
| EPS (Diluted) | $-0.68 +0.0% | $-0.68 +2.9% | $-0.70 +9.1% | $-0.77 +21.4% | $-0.98 |
| Shares (Diluted) | 8.3M -0.4% | 8.3M +10.1% | 7.5M -4.8% | 7.9M +51.9% | 5.2M |